Annual Drug Patent Expirations for SYMPROIC
Symproic is a drug marketed by Bdsi and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has fifty-five patent family members in twenty-five countries.
The generic ingredient in SYMPROIC is naldemedine tosylate. One supplier is listed for this compound. Additional details are available on the naldemedine tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
